JP2007534743A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007534743A5 JP2007534743A5 JP2007510157A JP2007510157A JP2007534743A5 JP 2007534743 A5 JP2007534743 A5 JP 2007534743A5 JP 2007510157 A JP2007510157 A JP 2007510157A JP 2007510157 A JP2007510157 A JP 2007510157A JP 2007534743 A5 JP2007534743 A5 JP 2007534743A5
- Authority
- JP
- Japan
- Prior art keywords
- cell activator
- antigen
- vaccine
- cat
- different
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56495904P | 2004-04-26 | 2004-04-26 | |
| US62906904P | 2004-11-18 | 2004-11-18 | |
| PCT/IB2005/001485 WO2005102385A1 (en) | 2004-04-26 | 2005-04-25 | Adjuvant composition and methods for its use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007534743A JP2007534743A (ja) | 2007-11-29 |
| JP2007534743A5 true JP2007534743A5 (https=) | 2008-06-19 |
Family
ID=34969994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007510157A Withdrawn JP2007534743A (ja) | 2004-04-26 | 2005-04-25 | アジュバント組成物およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20070218086A1 (https=) |
| EP (1) | EP1761278B1 (https=) |
| JP (1) | JP2007534743A (https=) |
| AT (1) | ATE419008T1 (https=) |
| AU (1) | AU2005235271A1 (https=) |
| CA (1) | CA2564562A1 (https=) |
| DE (1) | DE602005012097D1 (https=) |
| WO (1) | WO2005102385A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0212666D0 (en) * | 2002-05-31 | 2002-07-10 | Secr Defence | Immunogenic sequences |
| WO2005077411A2 (en) * | 2004-02-10 | 2005-08-25 | Innate Pharma | Composition and method for the treatment of carcinoma |
| WO2006067635A2 (en) * | 2004-12-20 | 2006-06-29 | Innate Pharma S.A. | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT |
| BRPI0608926A2 (pt) * | 2005-03-22 | 2010-11-03 | Innate Pharma | ativador de células t gamadelta, composição farmacêutica, uso de um ativador de células t gamadelta, composição de vacina, método de ativação de uma célula t gamadelta, célula t gamadelta, e, uso de uma célula t gamadelta |
| EP1924279A2 (en) * | 2005-09-07 | 2008-05-28 | The Secretary of State for Defence | Adjuvanted vaccine |
| ITMI20060366A1 (it) * | 2006-03-01 | 2007-09-02 | C4T S C A R L | Composti organo tiopirosfosfati metodo per prepararli e composizioni che li contengono |
| EP1878440A1 (en) * | 2006-07-13 | 2008-01-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds |
| WO2008012538A2 (en) * | 2006-07-25 | 2008-01-31 | The Secretary Of State For Defence | Live vaccine strains of francisella |
| EP2123285A1 (en) * | 2008-05-21 | 2009-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nucleosidic phosphoantigens for use in VGAMMA9DELTA2 T cell-mediated therapy |
| EP2324040B1 (en) | 2008-09-10 | 2014-01-01 | Innate Pharma | Novel polymorphic form of chdmapp, method of preparation thereof, and pharmaceutical composition comprising same |
| JP5676452B2 (ja) * | 2008-09-29 | 2015-02-25 | カディラ ファーマシューティカルズ リミテッド | ワクチンアジュバント |
| GB0901411D0 (en) * | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
| CN105101995A (zh) * | 2013-03-15 | 2015-11-25 | 宾夕法尼亚大学理事会 | 具有生物分子佐剂的疫苗 |
| KR102451441B1 (ko) * | 2020-06-25 | 2022-10-12 | 대한민국 | 신규 면역증강제 및 이를 포함하는 백신 조성물 |
| US20230226176A1 (en) * | 2020-06-26 | 2023-07-20 | Republic Of Korea (Animal And Plant Quarantine Agency) | Novel immune adjuvant and vaccine composition including the same |
| CN117794581A (zh) * | 2021-06-28 | 2024-03-29 | 拜奥迪斯私人有限公司 | 包含磷酸抗原的缀合物及其在治疗中的用途 |
| GB202114311D0 (en) * | 2021-10-06 | 2021-11-17 | Molecular Attraction Ab | New compositions |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8913737D0 (en) | 1989-06-15 | 1989-08-02 | Univ Birmingham | A novel anti-allergy treatment |
| US5639653A (en) | 1993-07-19 | 1997-06-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva Universtiy | Method for proliferating Vγ2Vδ2 T cells |
| US5688506A (en) | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
| WO1998050567A1 (en) | 1997-05-02 | 1998-11-12 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the prostate |
| BE1011282A3 (fr) * | 1997-07-14 | 1999-07-06 | Solvay | Composition a base de polyethylene et procede de fabrication d'objets faconnes a partir de la composition. |
| TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| FR2782722B1 (fr) * | 1998-09-01 | 2001-01-12 | Inst Nat Sante Rech Med | Nouveaux composes phosphoepoxydes, procede de fabrication et applications |
| FR2782721B1 (fr) | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | Nouveaux composes phosphohalohydrines, procede de fabrication et applications |
| ATE411805T1 (de) | 2001-07-20 | 2008-11-15 | Bioagency Ag | Organo-phosphorverbindungen zur aktivierung von gamma/delta-t-zellen |
| CN1561389A (zh) | 2001-07-25 | 2005-01-05 | 纽约大学 | 糖基神经酰胺作为用于抗传染病和癌症的疫苗的佐剂的用途 |
| WO2003038072A1 (en) * | 2001-10-31 | 2003-05-08 | Universite Libre De Bruxelles | Generation and use of new types of dendritic cells |
| FR2833266B1 (fr) * | 2001-12-11 | 2004-10-22 | Mayoly Spindler Lab | Nouveaux derives phosphonates, leur procede de preparation, leur utilisation comme modulateurs de l'activite des lymphocytes tgamma9 delta2 |
| DE60233576D1 (de) | 2002-12-02 | 2009-10-15 | Innate Pharma | Interleukin-2 und Gamma Delta T Zellaktivator enthaltende Zusammensetzungen und deren Verwendungen |
| WO2005021708A2 (en) * | 2003-05-16 | 2005-03-10 | University Of Maryland Biotechnology Institute | Bisphosphonates for prophylaxis and therapy against bioterrorism agents |
| CA2547008A1 (en) | 2003-12-02 | 2005-06-16 | Innate Pharma | New class of gamma delta t cells activators and use thereof |
-
2005
- 2005-04-25 JP JP2007510157A patent/JP2007534743A/ja not_active Withdrawn
- 2005-04-25 WO PCT/IB2005/001485 patent/WO2005102385A1/en not_active Ceased
- 2005-04-25 US US11/587,476 patent/US20070218086A1/en not_active Abandoned
- 2005-04-25 CA CA002564562A patent/CA2564562A1/en not_active Abandoned
- 2005-04-25 EP EP05747242A patent/EP1761278B1/en not_active Expired - Lifetime
- 2005-04-25 AU AU2005235271A patent/AU2005235271A1/en not_active Abandoned
- 2005-04-25 AT AT05747242T patent/ATE419008T1/de not_active IP Right Cessation
- 2005-04-25 DE DE602005012097T patent/DE602005012097D1/de not_active Expired - Lifetime